NCT07109674

Brief Summary

Compression therapy based on multilayer compression bandaging and com pression garment use remains the most efficient component of complex physical therapy (CPT) in lymphedema treatment. The proper self-application of compression bandages is generally considered as problematic. Adjustable compression wraps (ACW) have been proposed as an alternative to the commonly used short-stretch bandages for lymphedema. These systems allow easy application and removal for patients. They have been tested in patients with vascular disorders of the lower limbs and can be considered in breast cancer survivors with upper-limb lymphedema. The objective of this study was to compare the effectiveness, physical functioning and comfort of 2 types inelastic compression: adjustable compression wrap (reduction) and multi-layer compression bandaging at the intensive phase of treatment in advanced upper limb lymphedema among breast cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 7, 2025

Completed
Last Updated

August 7, 2025

Status Verified

June 1, 2025

Enrollment Period

1.1 years

First QC Date

June 23, 2025

Last Update Submit

July 31, 2025

Conditions

Keywords

breast cancer survivorscompression therapyadjustable compression wrapcompression bandaging

Outcome Measures

Primary Outcomes (4)

  • The assessment of limb volume

    Measurements including limb volumes were performed before the intervention, and after treatment in both groups. Circumferential upper limb measurements were taken with the arm abducted at 30°, starting at the level of the ulnar styloid, every 4 cm proximal to this point along both limbs. Calculation of limb segment volumes was carried out using a simplified frustum formula (summed truncated cone). The excess volume was the difference between the affected and unaffected limbs expressed in litres. The percentage reduction of the excess volume was obtained as follows: (excess volume before treatment - excess volume after treatment) x 100/excess volume before treatment.

    14 months

  • The assessment of physical functioning

    Patients rated their physical functioning of the affected limb on a numerical rating scale (NRS) based on the International Compression Club (ICC) Questionnaire - Part for Patients. The patients assessed their physical functioning (sum of ability to move wrist, elbow, shoulder; use a spoon; carry out work; complete household chores; practice sports' carry out leisure activities; social activities, on the Number Rating Scale (NRS; 0 = not able at all, 10 = completely able) before and after treatment in both groups.

    14 months

  • The assessment of disease - related symptoms

    Patients rated their disease-related symptoms based on the International Compression Club (ICC) Questionnaire - Part for Patients on the Number Rating (sum of pain; loss of muscle strength; heaviness; swelling; tight skin; tingling; leakage; NRS: 0 = no complaints, 10 = the highest intensity) before the intervention and after treatment in both groups.

    14 months

  • The assessment of compression comfort

    Patients rated their comfort and complications related to compression on a numerical rating scale (NRS) based on the International Compression Club (ICC) Questionnaire - Part for Patients. Complications of compression related to skin irritation; tender spots; skin damage; itching; warmth; throbbing; cramps; cutting in; slippage; local swelling; bulky feeling; too tight feeling (NRS: 0 = not present at all, 10 = very obviously present, sum of points) were assessed after treatment in both groups. Compression comfort including: easy donning; easy doffing; feeling immediately after donning; feeling during daytime; putting on clothes on compression; feeling at night; the appearance of the garment (NRS: 0 = not able at all, 10 = completely able, sum of points) was evaluated after treatment in both groups.

    14 months

Study Arms (2)

Adjustable compression wrap-reduction kit

EXPERIMENTAL

The objective of this study was to compare the effectiveness on volume reduction, physical functioning and comfort of inelastic compression: adjustable compression wrap (reduction) at the intensive phase of treatment in advanced upper limb lymphedema among breast cancer survivors

Device: adjustable compression device (type circaid® reduction kit, Medi-Bayreuth)

Compression bandaging

ACTIVE COMPARATOR

text

Device: Comparison of inelastic compression efficiency

Interventions

inelastic compression during intensive phase of physical therapy

Also known as: compression therapy
Adjustable compression wrap-reduction kit

The effect of compression on volume reduction, physical functioning, disease-related symptoms and comfort

Compression bandaging

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stage-II of lymphedema (according to ISL)
  • ≥20% excess limb volumes
  • positive pitting skin sign
  • absent signs of active cancer
  • absent of venous thrombosis

You may not qualify if:

  • active cancer during oncological treatment
  • using compression
  • stage-I of lymphedema (according to ISL)
  • \< 20 % excess limb volumes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University School of Physical Education

Krakow, Małopolska, 31-571, Poland

Location

Related Publications (2)

  • Ochalek K, Kurpiewska J, Gradalski T. Adjustable Compression Wraps (ACW) vs. Compression Bandaging (CB) in the Acute Phase of Breast Cancer-Related Arm Lymphedema Management-A Prospective Randomized Study. Biology (Basel). 2023 Mar 31;12(4):534. doi: 10.3390/biology12040534.

    PMID: 37106735BACKGROUND
  • Pujol-Blaya V, Salinas-Huertas S, Catasus ML, Pascual T, Belmonte R. Effectiveness of a precast adjustable compression system compared to multilayered compression bandages in the treatment of breast cancer-related lymphoedema: a randomized, single-blind clinical trial. Clin Rehabil. 2019 Apr;33(4):631-641. doi: 10.1177/0269215518821785. Epub 2019 Jan 4.

    PMID: 30607986BACKGROUND

Related Links

MeSH Terms

Conditions

LymphedemaBreast Neoplasms

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Comparison the physiotherapeutical intervention in breast cancer surivors
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2025

First Posted

August 7, 2025

Study Start

January 3, 2024

Primary Completion

February 1, 2025

Study Completion

March 30, 2025

Last Updated

August 7, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

* limb volume reduction * physical functioning * disease- related symptoms * comfort in compression

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
after publication start date: 01.10.2025 end date: 31.12.2025
Access Criteria
IPD will be available to reviewers of the manuscript submitted for publication.
More information

Locations